Generic Mounjaro, Zepbound May Be Coming, Rivaling Current GLP-1s
The landscape of weight-loss and diabetes medications may be shifting, as the U.S. Food and Drug Administration (FDA) has initiated a review of applications for generic versions of the popular medications Mounjaro and Zepbound. These generic alternatives, proposed by Swiss pharmaceutical firm Sandoz, could offer a more affordable option for patients seeking effective treatments. Both…
